These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 23912172
1. Pretransplantation GAD-autoantibody status to guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantation. Ringers J, van der Torren CR, van de Linde P, van der Boog PJ, Mallat MJ, Bonifacio E, Roep BO, de Fijter JW. Transplantation; 2013 Oct 27; 96(8):745-52. PubMed ID: 23912172 [Abstract] [Full Text] [Related]
2. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients. Huurman VA, Kalpoe JS, van de Linde P, Vaessen N, Ringers J, Kroes AC, Roep BO, De Fijter JW. Diabetes Care; 2006 Apr 27; 29(4):842-7. PubMed ID: 16567825 [Abstract] [Full Text] [Related]
3. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin. van de Linde P, Vd Boog PJ, Tysma OM, Elliott JF, Roelen DL, Claas FH, de Fijter JW, Roep BO. Clin Exp Immunol; 2007 Jul 27; 149(1):56-62. PubMed ID: 17459076 [Abstract] [Full Text] [Related]
4. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study. Stratta RJ, Alloway RR, Lo A, Hodge E. Transplantation; 2003 Apr 27; 75(8):1260-6. PubMed ID: 12717213 [Abstract] [Full Text] [Related]
5. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Cantarovich D, Karam G, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Le Normand L, Soulillou JP. Kidney Int; 1998 Oct 27; 54(4):1351-6. PubMed ID: 9767555 [Abstract] [Full Text] [Related]
6. Single-shot antithymocyte globuline and daclizumab induction in simultaneous pancreas and kidney transplant recipient: three-year results. Schulz T, Flecken M, Kapischke M, Busing M. Transplant Proc; 2005 May 27; 37(4):1818-20. PubMed ID: 15919476 [Abstract] [Full Text] [Related]
7. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin. Schulz T, Papapostolou G, Schenker P, Kapischke M. Transplant Proc; 2005 Mar 27; 37(2):1301-4. PubMed ID: 15848703 [Abstract] [Full Text] [Related]
9. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection. Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, Mortensen SA. J Heart Lung Transplant; 2005 Mar 27; 24(3):296-302. PubMed ID: 15737756 [Abstract] [Full Text] [Related]
10. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. Ailawadi G, Smith PW, Oka T, Wang H, Kozower BD, Daniel TM, Kron IL, Jones DR. J Thorac Cardiovasc Surg; 2008 Mar 27; 135(3):594-602. PubMed ID: 18329476 [Abstract] [Full Text] [Related]